查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2018431

泌尿系統市場：2026-2032年全球市場預測（依產品類型、應用、最終用戶、通路和技術分類）

Urology Market by Product Type, Application, End User, Distribution Channel, Technology - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年泌尿系統市場價值為642.8億美元，預計到2026年將成長至712.5億美元，複合年成長率為11.74%，到2032年將達到1398.5億美元。

主要市場統計數據
基準年 2025 642.8億美元
預計年份：2026年 712.5億美元
預測年份 2032 1398.5億美元
複合年成長率 (%) 11.74%

受人口結構變化、臨床實踐變革和加速技術創新驅動的泌尿系統醫療設備市場不斷發展，需要明確的策略方向。

泌尿系統醫療設備市場格局正受到臨床需求、人口趨勢和技術快速創新三者共同作用的重塑。隨著人口老化，慢性及急性泌尿系統疾病的發生率不斷上升，醫療服務模式也正從住院治療轉向門診治療。同時，影像技術和微創治療設備的進步正在改變臨床路徑和臨床醫生的預期，迫使醫療機構重新評估其資金配置和籌資策略。

微創技術、診斷成像技術的進步、一次性產品的採用以及數位化分銷如何從根本上重塑泌尿系統臨床實踐和經營模式。

近年來，醫療器材產業經歷了變革性的變化，產品生命週期、採購慣例和病患就醫路徑都發生了重塑。微創技術，在先進影像和雷射技術的支持下，降低了手術門檻，縮短了住院時間，從而推動了手術向門診手術中心和診所的持續轉移。同時，在感染控制、操作簡便性和醫​​療總成本計算方式變化等因素的推動下，一次性醫療設備的普及速度也正在加快。

評估 2025 年美國關稅措施對泌尿系統醫療設備。

美國2025年實施的關稅調整的累積影響，為泌尿系統醫療設備的整個供應鏈帶來了新的限制和獎勵。依賴進口零件的製造商面臨著不斷上漲的投入成本，許多公司正在重新審視籌資策略，並加快本地化生產和認證替代供應商的步伐。這些調整正在影響定價策略、庫存政策和供應商契約，促使相關人員重新評估長期供應商關係和合約柔軟性。

詳細的細分框架，突顯了影響臨床效用、採購行為和商業策略的產品、應用、最終用戶、通路和技術差異。

對市場區隔的詳細分析揭示了產品、應用、最終用戶、分銷和技術等維度上的需求、臨床效用和採購行為的差異。依產品類型分類，市場分為一次性醫療器材和可重複使用醫療器材。一次性醫療器械包括導尿管和支架，其中導尿管又細分為Foley導管和間歇導尿管，支架則分為腎造瘻支架和輸尿管支架。可重複使用醫療器材包括內視鏡和手術器械，其中內視鏡又分為軟式內視鏡內視鏡和硬式內視鏡。這些產品分類與感染控制重點、手術量和資本投資週期密切相關。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢影響泌尿系統醫療設備的採購、監管參與和供應鏈韌性。

區域趨勢影響著美洲、歐洲、中東和非洲以及亞太地區的競爭重點和投資選擇，每個地區都有其獨特的監管、報銷和供應鏈環境。在美洲，私立醫療機構、綜合醫院系統和不斷擴張的門診手術中心共同推動了對能夠縮短手術時間並實現當日出院的醫療設備的需求。同時，耗材的分銷模式也擴大採用直接採購和電子商務。

產業競爭由策略聯盟、服務主導產品和服務以及產業重組驅動，重點在於整合解決方案、售後服務和擴充性。

泌尿系統醫療設備生態系統的競爭趨勢日益呈現出策略多元化、夥伴關係和服務導向經營模式的特徵。領先的製造商正投資於捆綁式解決方案，將醫療設備與培訓、資訊服務和維護合約相結合，以深化客戶關係並創造持續的收入來源。醫療設備製造商、影像服務提供者和臨床中心之間的策略合作正在加速檢驗週期，並推動整合治療方案的更廣泛應用。

為產業領導者提供實際有效的措施，以加強供應鏈、實現臨床差異化並拓展服務型商業模式，從而確保永續成長。

為了應對不斷變化的環境並實現永續成長，產業領導者應採取兼顧供應鏈韌性、臨床差異化和商業性敏捷性的策略。首先，供應商多元化和關鍵生產流程的地域多角化化可以降低關稅波動帶來的風險並保障前置作業時間，同時投資於庫存可視性和靈活的合約條款可以增強營運韌性。其次，優先考慮能夠展現可衡量的臨床和經濟效益的產品特性，例如縮短治療時間、降低感染風險或降低兒科總成本，可以增強注重價值的買家的採購優勢。

結合臨床文獻、監管審查、專家訪談和檢驗的穩健、多方面的調查方法，得出了可操作和檢驗的行業見解。

本研究途徑整合了多學科見解，以確保分析的嚴謹性、多角度驗證和實際應用價值。二次研究系統性地回顧了同儕審查的臨床文獻、監管申報文件、操作指南和公共文件，以了解臨床路徑、技術應用和合規要求。一次研究則對臨床醫生、採購經理、供應鏈經理和產品開發人員進行了結構化訪談，以確定實際限制因素、選擇因素和應用障礙。製造商的技術文件和產品註冊資訊構成了比較醫療設備規格和功能的基礎。

泌尿系統領域將技術進步和供應鏈挑戰轉化為競爭優勢所需的策略重點和緊急行動概述。

總而言之，泌尿系統醫療設備產業正處於轉折點，臨床創新、不斷演變的採購流程和供應鏈壓力交織在一起。微創技術的興起、一次性感染控制產品的普及以及先進成像和雷射技術的整合正在重塑臨床路徑和採購方的預期。同時，關稅以及採購和管理體制的區域差異所導致的成本波動，要求企業在採購、定價和商業性合作方面保持靈活。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章泌尿系統市場：依產品類型分類

  • 一次性醫療設備
    • 導管
      • Foley導管
      • 間歇性導尿管
    • 支架
      • 腎造瘻支架
      • 輸尿管支架
  • 可重複使用的醫療設備
    • 內視鏡
      • 軟式內視鏡
      • 硬式內視鏡
    • 手術器械

第9章：泌尿系統市場：依應用領域分類

  • 良性攝護腺增生的治療
  • 癌症診斷
  • 移除石頭
  • 尿失禁的治療

第10章：泌尿系統市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第11章泌尿系統市場：依分銷通路分類

  • 電子商務
  • 醫院採購
  • 零售藥房

第12章泌尿系統市場：依技術分類

  • 醫學影像技術
    • 電腦斷層掃描
    • MRI
    • 超音波
  • 雷射技術

第13章泌尿系統市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章泌尿系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章泌尿系統市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國泌尿系統市場

第17章：中國泌尿系統市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast Group
  • CONMED Corporation
  • Cook Group Incorporated
  • Dornier MedTech GmbH
  • Fujifilm Holdings Corporation
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • Karl Storz SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Procept BioRobotics Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers AG
  • Stryker Corporation
  • Teleflex Incorporated
  • UroViu Corporation
Product Code: MRR-0360AB17DF5A

The Urology Market was valued at USD 64.28 billion in 2025 and is projected to grow to USD 71.25 billion in 2026, with a CAGR of 11.74%, reaching USD 139.85 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 64.28 billion
Estimated Year [2026] USD 71.25 billion
Forecast Year [2032] USD 139.85 billion
CAGR (%) 11.74%

A clear and strategic orientation to the evolving urology device landscape driven by demographic shifts, clinical practice change, and accelerating technological innovation

The urology device landscape is being reshaped by converging clinical needs, demographic trends, and rapid technological innovation. Aging populations are increasing the prevalence of chronic and acute urological conditions, while care-delivery models are shifting procedures from inpatient to ambulatory settings. In parallel, advances in imaging and minimally invasive tools are changing clinical pathways and clinician expectations, prompting providers to reassess capital allocation and procurement strategies.

Consequently, manufacturers, distributors, and health systems are navigating a more complex environment where regulatory scrutiny, infection-prevention priorities, and sustainability considerations intersect. Payers and providers seek value through outcome-driven procurement and long-term service relationships, and digital channels are beginning to alter traditional distribution dynamics. Taken together, these forces demand strategic clarity about product portfolios, channel investments, and partnerships that can sustain clinical relevance and commercial performance amid accelerating change.

How minimally invasive techniques, imaging advances, single-use adoption and digital distribution are fundamentally reshaping clinical practice and commercial models in urology

Over recent years the industry has experienced transformative shifts that are redefining product lifecycles, procurement practices, and patient pathways. Minimally invasive techniques, fueled by refined imaging and laser technology, are lowering thresholds for procedural intervention and shortening length of stay, which in turn supports the continued migration of procedures to ambulatory surgical centers and outpatient clinics. Simultaneously, the adoption of single-use disposable devices has accelerated, driven by infection-control priorities, operational simplicity, and changes in total cost-of-care calculations.

At the same time, digital integration and advanced imaging modalities are enabling earlier diagnosis and more precise interventions, while artificial intelligence and enhanced visualization tools are beginning to influence device design and clinical workflows. Distribution channels are adapting as e-commerce and direct-to-provider models gain traction alongside traditional hospital procurement, creating new competitive pressures and pricing dynamics. As these shifts continue, companies that integrate cross-functional expertise-combining device innovation, service delivery, and data-driven clinical evidence-will be better positioned to capture opportunities and mitigate the operational and regulatory headwinds that accompany rapid sector transformation.

Assessing the wide-ranging operational and strategic consequences of United States tariff actions in 2025 on sourcing, production, procurement and pricing dynamics across urology devices

The cumulative effects of tariff changes implemented in 2025 in the United States have created a new set of constraints and incentives across the urology device supply chain. Manufacturers reliant on imported components have faced increased input costs, prompting many to reassess sourcing strategies and accelerate initiatives to regionalize production or qualify alternative suppliers. These adjustments have affected pricing strategies, inventory policies, and supplier contracts, leading stakeholders to re-evaluate long-term supplier relationships and contractual flexibility.

Healthcare providers and distributors have responded by intensifying negotiations, prioritizing value-based purchasing, and increasing scrutiny of total cost implications, including service and consumable components. In addition, some device makers have shifted higher-value assembly and final testing to domestic facilities to reduce exposure to tariff volatility and to maintain more predictable lead times. Regulatory compliance and customs complexity have added administrative burdens, which in turn favor larger organizations with robust supply-chain functions. Overall, the tariff environment has accelerated structural adjustments in sourcing, production footprints, and commercial terms, prompting both near-term operational responses and longer-term strategic repositioning among manufacturers and purchasers.

Deep segmentation framework highlighting product, application, end-user, channel and technology distinctions that drive clinical utility, procurement behavior and commercial strategy

A granular view of segmentation reveals differentiated demand, clinical utility, and procurement behavior across product, application, end-user, distribution, and technology dimensions. By product type, the landscape separates into disposable devices and reusable devices, where disposable devices encompass catheters and stents; catheters further segment into Foley catheters and intermittent catheters while stents further divide into nephrostomy stents and ureteral stents. Reusable devices include endoscopes and surgical instruments, and endoscopes can be further categorized into flexible endoscopes and rigid endoscopes. These product distinctions correlate strongly with infection-control priorities, procedure volumes, and capital-investment cycles.

Applications map to distinct clinical drivers including benign prostatic hyperplasia treatment, cancer diagnosis, stone removal, and urinary incontinence management, each of which has specific clinical workflows, reimbursement considerations, and device-performance requirements. End users vary among ambulatory surgical centers, clinics, and hospitals, and each setting has unique procurement governance, budget horizons, and operational constraints. Distribution channels range across e-commerce, hospital purchases, and retail pharmacies, with digital channels progressively influencing purchasing behaviors for consumables and smaller devices. Technology segmentation encompasses imaging technology and laser technology; imaging technology itself spans CT scan, MRI, and ultrasound modalities, which inform diagnostic pathways and procedural planning. Understanding these intersecting segments enables targeted product development, differentiated sales strategies, and service models tailored to clinical needs and buyer preferences.

Regional dynamics across Americas, Europe, Middle East & Africa and Asia-Pacific shaping procurement, regulatory engagement, and supply-chain resilience for urology devices

Regional dynamics are shaping competitive priorities and investment choices across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting distinct regulatory, reimbursement, and supply-chain contexts. In the Americas, a mix of private providers, consolidated hospital systems, and an expanding ambulatory surgical center footprint have heightened demand for devices that reduce procedure time and support same-day discharge, while distribution models reflect growing adoption of direct procurement and e-commerce for consumables.

Across Europe, the Middle East & Africa, procurement is often influenced by public payers and centralized purchasing mechanisms; cost-containment pressures coexist with a high bar for clinical evidence and reprocessing standards, which sustains the relevance of reusable equipment in some markets. In the Asia-Pacific region, rapid healthcare investment, expanding procedural volumes, and a focus on local manufacturing capacity are accelerating adoption of minimally invasive technologies, imaging upgrades, and hybrid distribution strategies. These regional distinctions imply that commercial tactics should be localized, regulatory engagement must be proactive, and supply-chain resilience tailored to each region's mix of regulatory complexity, procurement maturity, and infrastructure development.

Industry competitive dynamics driven by strategic partnerships, service-led offerings, and consolidation as players prioritize integrated solutions, aftersales and scalability

Competitive dynamics within the urology device ecosystem are increasingly characterized by strategic diversification, partnerships, and service-oriented business models. Leading manufacturers are investing in bundled solutions that combine devices with training, data services, and maintenance agreements to deepen customer relationships and create recurring revenue streams. Strategic collaborations between device makers, imaging providers, and clinical centers are accelerating validation cycles and supporting broader adoption of integrated procedural solutions.

At the same time, smaller innovators are focusing on niche indications, disposable alternatives, and technology-enabled differentiation to gain clinical traction and attract distribution partners. Consolidation activity continues as companies seek scale in manufacturing, regulatory expertise, and aftermarket service capabilities, while contract terms and service-level commitments have become central considerations in procurement decisions. In this environment, companies that align R&D priorities with clear clinical value propositions and robust post-sale support will be better positioned to secure durable contracts and navigate evolving reimbursement and procurement pressures.

Practical, high-impact actions for industry leaders to strengthen supply chains, differentiate clinically, and expand service-oriented commercial models to secure durable growth

To navigate the evolving landscape and capture sustainable growth, industry leaders should pursue a combination of supply-chain resilience, clinical differentiation, and commercial agility. First, diversifying supplier bases and regionalizing critical manufacturing steps reduces exposure to tariff volatility and protects lead times, while investments in inventory visibility and flexible contract terms improve operational resilience. Second, prioritizing product features that demonstrate measurable clinical and economic benefits-such as reduced procedure time, lower infection risk, or decreased total episode cost-will enhance procurement positioning with value-minded buyers.

Third, building service and training packages that accompany device sales increases customer retention and creates predictable revenue streams, particularly for providers shifting procedures to outpatient settings. Fourth, expanding digital and direct-to-provider distribution channels for consumables and lower-cost devices complements traditional hospital purchasing and enables faster market access. Finally, engaging proactively with regulators and payers to communicate clinical evidence and real-world outcomes will support favorable adoption and reimbursement decisions. Executed together, these actions create a defensible strategic posture grounded in operational reliability, clinical relevance, and commercial flexibility.

Robust, multi-method research methodology combining clinical literature, regulatory review, expert interviews and validation to produce actionable and verifiable industry insights

The research approach combined multi-disciplinary inputs to ensure analytical rigor, triangulation, and practical relevance. Secondary research involved systematic review of peer-reviewed clinical literature, regulatory filings, procedural guidelines, and public policy documents to map clinical pathways, technology adoption, and compliance requirements. Primary research included structured interviews with clinicians, procurement leaders, supply-chain managers, and product developers to capture real-world operational constraints, preference drivers, and adoption barriers. Data from manufacturer technical documentation and product registries informed device specifications and functional comparisons.

Qualitative insights were validated against purchaser procurement frameworks and clinical experts to ensure alignment with practice patterns and purchasing rationales. The methodology prioritized transparency in assumptions, explicit documentation of data sources, and a layered validation process comprising internal cross-functional review and external expert validation. Limitations include variability in institutional procurement practices and the evolving nature of tariffs and regulatory guidance, which were addressed through sensitivity analyses and scenario planning to illuminate plausible strategic responses rather than singular deterministic outcomes.

Concluding synthesis of strategic priorities and urgent actions required to translate technological advances and supply-chain challenges into competitive advantage in urology

In summary, the urology device environment is at an inflection point where clinical innovation, procurement evolution, and supply-chain pressures intersect. The shift toward minimally invasive techniques, the rise of disposable options for infection control, and the integration of advanced imaging and laser technologies are reshaping clinical pathways and buyer expectations. Concurrently, tariff-driven cost dynamics and regional variations in procurement and regulatory regimes require companies to be nimble in sourcing, pricing, and commercial engagement.

Looking forward, success will depend on an integrated approach that aligns product development with clear clinical value, reinforces service and training capabilities, and builds supply-chain resilience. Providers and manufacturers who proactively adapt to outpatient migration, invest in digital and distribution flexibility, and collaborate across clinical, regulatory, and commercial functions will be better positioned to deliver improved patient outcomes while maintaining financial and operational stability. The time to act is immediate, as strategic choices made now will determine who captures advantage as the landscape continues to evolve.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Urology Market, by Product Type

  • 8.1. Disposable Devices
    • 8.1.1. Catheters
      • 8.1.1.1. Foley Catheters
      • 8.1.1.2. Intermittent Catheters
    • 8.1.2. Stents
      • 8.1.2.1. Nephrostomy Stents
      • 8.1.2.2. Ureteral Stents
  • 8.2. Reusable Devices
    • 8.2.1. Endoscopes
      • 8.2.1.1. Flexible Endoscopes
      • 8.2.1.2. Rigid Endoscopes
    • 8.2.2. Surgical Instruments

9. Urology Market, by Application

  • 9.1. Benign Prostatic Hyperplasia Treatment
  • 9.2. Cancer Diagnosis
  • 9.3. Stone Removal
  • 9.4. Urinary Incontinence Management

10. Urology Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals

11. Urology Market, by Distribution Channel

  • 11.1. E-Commerce
  • 11.2. Hospital Purchases
  • 11.3. Retail Pharmacies

12. Urology Market, by Technology

  • 12.1. Imaging Technology
    • 12.1.1. CT Scan
    • 12.1.2. MRI
    • 12.1.3. Ultrasound
  • 12.2. Laser Technology

13. Urology Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Urology Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Urology Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Urology Market

17. China Urology Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Becton, Dickinson and Company
  • 18.6. Boston Scientific Corporation
  • 18.7. Coloplast Group
  • 18.8. CONMED Corporation
  • 18.9. Cook Group Incorporated
  • 18.10. Dornier MedTech GmbH
  • 18.11. Fujifilm Holdings Corporation
  • 18.12. Intuitive Surgical, Inc.
  • 18.13. Johnson & Johnson
  • 18.14. Karl Storz SE & Co. KG
  • 18.15. Medtronic plc
  • 18.16. Olympus Corporation
  • 18.17. Procept BioRobotics Corporation
  • 18.18. Richard Wolf GmbH
  • 18.19. Siemens Healthineers AG
  • 18.20. Stryker Corporation
  • 18.21. Teleflex Incorporated
  • 18.22. UroViu Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL UROLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL UROLOGY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL UROLOGY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL UROLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL UROLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL UROLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL UROLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UROLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL UROLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES UROLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA UROLOGY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL UROLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL UROLOGY MARKET SIZE, BY FOLEY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL UROLOGY MARKET SIZE, BY FOLEY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL UROLOGY MARKET SIZE, BY FOLEY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL UROLOGY MARKET SIZE, BY INTERMITTENT CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL UROLOGY MARKET SIZE, BY INTERMITTENT CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL UROLOGY MARKET SIZE, BY INTERMITTENT CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL UROLOGY MARKET SIZE, BY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL UROLOGY MARKET SIZE, BY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL UROLOGY MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL UROLOGY MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL UROLOGY MARKET SIZE, BY NEPHROSTOMY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL UROLOGY MARKET SIZE, BY NEPHROSTOMY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL UROLOGY MARKET SIZE, BY NEPHROSTOMY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL UROLOGY MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL UROLOGY MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL UROLOGY MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL UROLOGY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL UROLOGY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL UROLOGY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL UROLOGY MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL UROLOGY MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL UROLOGY MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL UROLOGY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL UROLOGY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL UROLOGY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL UROLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL UROLOGY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL UROLOGY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL UROLOGY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL UROLOGY MARKET SIZE, BY CANCER DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL UROLOGY MARKET SIZE, BY CANCER DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL UROLOGY MARKET SIZE, BY CANCER DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL UROLOGY MARKET SIZE, BY STONE REMOVAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL UROLOGY MARKET SIZE, BY STONE REMOVAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL UROLOGY MARKET SIZE, BY STONE REMOVAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL UROLOGY MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL UROLOGY MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL UROLOGY MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL UROLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL UROLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL UROLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL UROLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL UROLOGY MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL UROLOGY MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL UROLOGY MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL UROLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL UROLOGY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL UROLOGY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL UROLOGY MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL UROLOGY MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL UROLOGY MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL UROLOGY MARKET SIZE, BY HOSPITAL PURCHASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL UROLOGY MARKET SIZE, BY HOSPITAL PURCHASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL UROLOGY MARKET SIZE, BY HOSPITAL PURCHASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL UROLOGY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL UROLOGY MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL UROLOGY MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL UROLOGY MARKET SIZE, BY CT SCAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL UROLOGY MARKET SIZE, BY CT SCAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL UROLOGY MARKET SIZE, BY CT SCAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL UROLOGY MARKET SIZE, BY MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL UROLOGY MARKET SIZE, BY MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL UROLOGY MARKET SIZE, BY MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL UROLOGY MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL UROLOGY MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL UROLOGY MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL UROLOGY MARKET SIZE, BY LASER TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL UROLOGY MARKET SIZE, BY LASER TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL UROLOGY MARKET SIZE, BY LASER TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL UROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS UROLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS UROLOGY MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS UROLOGY MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS UROLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS UROLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA UROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA UROLOGY MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA UROLOGY MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA UROLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA UROLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA UROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA UROLOGY MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA UROLOGY MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA UROLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA UROLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE UROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE UROLOGY MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE UROLOGY MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE UROLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE UROLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST UROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST UROLOGY MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST UROLOGY MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST UROLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST UROLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA UROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA UROLOGY MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA UROLOGY MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA UROLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA UROLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC UROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC UROLOGY MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC UROLOGY MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC UROLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC UROLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL UROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN UROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN UROLOGY MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN UROLOGY MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN UROLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN UROLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. GCC UROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. GCC UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 207. GCC UROLOGY MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 208. GCC UROLOGY MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 209. GCC UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 210. GCC UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 211. GCC UROLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. GCC UROLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. GCC UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. GCC UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. GCC UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION UROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION UROLOGY MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION UROLOGY MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION UROLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION UROLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS UROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS UROLOGY MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS UROLOGY MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS UROLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS UROLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 240. G7 UROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. G7 UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. G7 UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 243. G7 UROLOGY MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 244. G7 UROLOGY MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 245. G7 UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 246. G7 UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 247. G7 UROLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. G7 UROLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. G7 UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. G7 UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. G7 UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. NATO UROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. NATO UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. NATO UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 255. NATO UROLOGY MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 256. NATO UROLOGY MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 257. NATO UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 258. NATO UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 259. NATO UROLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. NATO UROLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. NATO UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. NATO UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. NATO UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL UROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES UROLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES UROLOGY MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES UROLOGY MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES UROLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES UROLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA UROLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA UROLOGY MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA UROLOGY MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA UROLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA UROLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)